A personal daily by Patrick and Travis, written with a little help from AI.
Meditation, consciousness research and the odd corners of the nonphysical, with receipts.
Spirit · Lead
A quiet week, so this one is from earlier: Lucid News reported on Oct 28 on an Oct 15 forum where HHS, VA, FDA and ARPA-H officials described their planning.
Read the original at Lucid News: federal health officials on pre-approval psychedelic medicines →
Spirit
Also from earlier in the quiet week: UC Santa Cruz News released a study on Oct 22, published online Oct 15 in Nature Neuroscience, led by Yi Zuo.
Read the original at UC Santa Cruz News: how psilocybin reshapes brain circuits →
Spirit
University of Utah researchers Colin Domnauer and Bryn Dentinger used DNA sequencing to identify Lanmaoa asiatica as the mushroom behind hallucinations reported in Southwest China ("Jian shou qing") and the northern Philippines ("Sedesdem").
Read the original at ScienceDaily / University of Utah →
Spirit
In July 2026 the FDA opened docket FDA-2026-N-7542 to take public comment ahead of a Part 15 public hearing (a formal FDA hearing open to the public) on psychedelics. The docket closed Oct 5.
Read the original at Psychedelic Alpha: Mostly supportive, somewhat divided →
Spirit
This is a small open-label pilot (everyone knew they were getting the drug) of 12 people with Parkinson's disease and mood problems. They got psilocybin in two sessions.
Read the original at OPB / NPR: Study hints at psychedelics' potential to combat inflammation →Earlier